Guangzheng Eye Hospital Group Co., Ltd.
Simbols: 002524.SZ
SHZ
4.16
CNYTirgus cena šodien
211.9824
P/E koeficients
0.0000
PEG koeficients
2.12B
MRK Cap
- 0.00%
DIV ienesīgums
Guangzheng Eye Hospital Group Co., Ltd. (002524-SZ) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 307.1 | 91.1 | 65.4 | 89.3 | |||||||||||||||||
balance-sheet.row.short-term-investments | -143.74 | 0 | -68 | 31 | |||||||||||||||||
balance-sheet.row.net-receivables | 782.74 | 190.2 | 143.5 | 192.1 | |||||||||||||||||
balance-sheet.row.inventory | 151.98 | 29.6 | 57.3 | 53.2 | |||||||||||||||||
balance-sheet.row.other-current-assets | 23.34 | 5.6 | 3.3 | 5.9 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1265.15 | 316.5 | 269.5 | 340.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2511.93 | 619.7 | 687.6 | 744.2 | |||||||||||||||||
balance-sheet.row.goodwill | 1511.56 | 377.3 | 378.5 | 517.2 | |||||||||||||||||
balance-sheet.row.intangible-assets | 159.62 | 40 | 37 | 55.7 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1671.19 | 417.2 | 415.5 | 572.8 | |||||||||||||||||
balance-sheet.row.long-term-investments | 181.47 | 0 | 94 | 7.2 | |||||||||||||||||
balance-sheet.row.tax-assets | 182.98 | 49.7 | 40.6 | 40.5 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 376.81 | 146.3 | 50.2 | 123.6 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 4924.38 | 1232.9 | 1288 | 1488.3 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 6189.53 | 1549.4 | 1557.5 | 1828.9 | |||||||||||||||||
balance-sheet.row.account-payables | 1052.98 | 261.3 | 275.5 | 262.8 | |||||||||||||||||
balance-sheet.row.short-term-debt | 1503.14 | 383.2 | 360.8 | 289 | |||||||||||||||||
balance-sheet.row.tax-payables | 63.8 | 16 | 10.9 | 15.2 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 2004.97 | 493.8 | 448.9 | 505.7 | |||||||||||||||||
Deferred Revenue Non Current | 13.05 | 0 | 0 | 30 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.33 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 29.31 | 7.7 | 107.5 | 10.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 2047.9 | 507.6 | 468.6 | 507.2 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 1693.54 | 417.3 | 448.4 | 475.7 | |||||||||||||||||
balance-sheet.row.total-liab | 5054.77 | 1263.5 | 1282.7 | 1487.5 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 2068.45 | 518 | 515.4 | 516.4 | |||||||||||||||||
balance-sheet.row.retained-earnings | -1219.92 | -299.7 | -308.4 | -214.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 200.82 | 0 | 46.5 | 16.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 74.22 | 65 | 19.6 | 21.6 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1123.57 | 283.3 | 273.1 | 340.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6189.53 | 1549.4 | 1557.5 | 1828.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 11.18 | 2.6 | 1.7 | 0.8 | |||||||||||||||||
balance-sheet.row.total-equity | 1134.75 | 285.9 | 274.8 | 341.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6189.53 | - | - | - | |||||||||||||||||
Total Investments | 75.6 | 19.1 | 26 | 38.2 | |||||||||||||||||
balance-sheet.row.total-debt | 3508.11 | 877 | 809.7 | 794.7 | |||||||||||||||||
balance-sheet.row.net-debt | 3201.01 | 785.9 | 744.3 | 736.4 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 18.29 | -77.8 | 36.4 | 32.1 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | -23.36 | 100 | 106.4 | 62.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | -3.08 | -2.2 | -1.2 | -10.9 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0.15 | 2.5 | 6 | 13.1 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -108.9 | 27.9 | 32.8 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 48.7 | -23.6 | 28.8 | ||||||||||||||||
cash-flows.row.inventory | 0 | -8.7 | 16.9 | -3.9 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -146.7 | 35.8 | 18.8 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2.2 | -1.2 | -10.9 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 39.32 | 210.7 | -30.1 | 25.2 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 31.18 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -21.71 | -40.7 | -52.5 | -62.1 | ||||||||||||||||
cash-flows.row.acquisitions-net | 25.73 | 1.8 | 83.9 | 194.5 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -25.73 | -116.4 | -262.1 | -543 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 4.07 | 54.7 | 228.4 | 33.9 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0.92 | 0 | 3.5 | 7.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -6.23 | -100.6 | 1.2 | -369.6 | ||||||||||||||||
cash-flows.row.debt-repayment | -170.2 | -232 | -467 | -130.7 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 3.1 | 22.7 | 29.5 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3.1 | -22.7 | -29.5 | ||||||||||||||||
cash-flows.row.dividends-paid | -15.3 | -11.9 | -16.5 | -46.6 | ||||||||||||||||
cash-flows.row.other-financing-activites | 68.2 | 232.2 | 273.7 | 255.3 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -53.06 | -11.8 | -209.8 | 78 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -3.24 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -29.13 | 12 | -63.2 | -136.6 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 255.13 | 57 | 45 | 108.3 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 284.26 | 45 | 108.3 | 244.8 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 31.18 | 124.3 | 145.4 | 155 | ||||||||||||||||
cash-flows.row.capital-expenditure | -21.71 | -40.7 | -52.5 | -62.1 | ||||||||||||||||
cash-flows.row.free-cash-flow | 9.46 | 83.6 | 92.9 | 92.9 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1058.07 | 1074.9 | 767.4 | 1044.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 689.43 | 697.9 | 575.9 | 709.2 | |||||||||||||||||
income-statement-row.row.gross-profit | 368.64 | 377 | 191.5 | 335.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 5.26 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 37.86 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 191.47 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0.04 | 0.9 | 104.7 | 89.4 | |||||||||||||||||
income-statement-row.row.operating-expenses | 337.23 | 328.7 | 281.5 | 334.3 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 1026.66 | 1026.6 | 857.4 | 1043.5 | |||||||||||||||||
income-statement-row.row.interest-income | 0.76 | 0.7 | 0.8 | 0.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 39.08 | 38.8 | 36.3 | 37.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 191.47 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.04 | 0.9 | -174.2 | -32.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.04 | 0.9 | 104.7 | 89.4 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0.04 | 0.9 | -174.2 | -32.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 39.08 | 38.8 | 36.3 | 37.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 40.76 | 100.3 | 100 | 106.4 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 35.43 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -5.32 | 7 | 98.6 | 77 | |||||||||||||||||
income-statement-row.row.income-before-tax | -5.28 | 7.9 | -75.6 | 44.9 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -3.23 | -1.8 | 2.2 | 8.5 | |||||||||||||||||
income-statement-row.row.net-income | -1.62 | 9.3 | -77.8 | 36.9 |
Biežāk uzdotie jautājumi
Kas ir Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) kopējie aktīvi?
Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) kopējie aktīvi ir 1549365088.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir 447607126.000.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.351.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 0.001.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.009.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.007.
Kāda ir Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 9255045.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 877008780.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 328663038.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 65054312.000.